This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Elie Hadchity: Innovator in Cancer Treatment
Introduction
Elie Hadchity is a notable inventor based in Lyons, France. He has made significant contributions to the field of cancer treatment, particularly in the area of squamous cell carcinoma. His innovative approach combines radiotherapy with a therapeutic agent that targets specific cancer cell proteins.
Latest Patents
Elie Hadchity holds a patent for the treatment of squamous cell carcinoma using HSP27 antisense oligonucleotides in conjunction with radiotherapy. This patent addresses the treatment of squamous head and neck cancers by utilizing a therapeutic agent that reduces the levels of HSP27 in cancer cells. The use of antisense oligonucleotide therapeutic agents represents a promising advancement in cancer therapy.
Career Highlights
Elie Hadchity is affiliated with the University of British Columbia, where he continues to engage in research and development in the field of oncology. His work has the potential to improve treatment outcomes for patients suffering from squamous cell carcinomas.
Collaborations
Elie collaborates with Claire Rodriguez-Lafrasse, contributing to the advancement of cancer treatment methodologies. Their partnership exemplifies the importance of teamwork in scientific research.
Conclusion
Elie Hadchity's innovative work in cancer treatment showcases the potential of combining traditional therapies with novel therapeutic agents. His contributions are paving the way for more effective treatments for squamous cell carcinoma.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile